These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 26689513

  • 1. Single nucleotide polymorphisms in DKK3 gene are associated with prostate cancer risk and progression.
    Kim MS, Lee HN, Kim HJ, Myung SC.
    Int Braz J Urol; 2015; 41(5):869-97. PubMed ID: 26689513
    [Abstract] [Full Text] [Related]

  • 2. Genetic variations in VDR associated with prostate cancer risk and progression in a Korean population.
    Oh JJ, Byun SS, Lee SE, Hong SK, Jeong CW, Kim D, Kim HJ, Myung SC.
    Gene; 2014 Jan 01; 533(1):86-93. PubMed ID: 24120391
    [Abstract] [Full Text] [Related]

  • 3. HNF1B polymorphism associated with development of prostate cancer in Korean patients.
    Kim HJ, Bae JS, Lee J, Chang IH, Kim KD, Shin HD, Han JH, Lee SY, Kim W, Myung SC.
    Urology; 2011 Oct 01; 78(4):969.e1-6. PubMed ID: 21982019
    [Abstract] [Full Text] [Related]

  • 4. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
    Sun J, Wiklund F, Zheng SL, Chang B, Bälter K, Li L, Johansson JE, Li G, Adami HO, Liu W, Tolin A, Turner AR, Meyers DA, Isaacs WB, Xu J, Grönberg H.
    J Natl Cancer Inst; 2005 Apr 06; 97(7):525-32. PubMed ID: 15812078
    [Abstract] [Full Text] [Related]

  • 5. The association of 5-alpha reductase type 2 (SRD5A2) gene polymorphisms with prostate cancer in a Korean population.
    Choi SY, Kim HJ, Cheong HS, Myung SC.
    Korean J Urol; 2015 Jan 06; 56(1):19-30. PubMed ID: 25598933
    [Abstract] [Full Text] [Related]

  • 6. Estrogen receptor beta polymorphism is associated with prostate cancer risk.
    Thellenberg-Karlsson C, Lindström S, Malmer B, Wiklund F, Augustsson-Bälter K, Adami HO, Stattin P, Nilsson M, Dahlman-Wright K, Gustafsson JA, Grönberg H.
    Clin Cancer Res; 2006 Mar 15; 12(6):1936-41. PubMed ID: 16551880
    [Abstract] [Full Text] [Related]

  • 7. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer.
    Chen YC, Giovannucci E, Lazarus R, Kraft P, Ketkar S, Hunter DJ.
    Cancer Res; 2005 Dec 15; 65(24):11771-8. PubMed ID: 16357190
    [Abstract] [Full Text] [Related]

  • 8. Comprehensive evaluation of genetic variation in the IGF1 gene and risk of prostate cancer.
    Johansson M, McKay JD, Stattin P, Canzian F, Boillot C, Wiklund F, Adami HO, Bälter K, Grönberg H, Kaaks R.
    Int J Cancer; 2007 Feb 01; 120(3):539-42. PubMed ID: 17096324
    [Abstract] [Full Text] [Related]

  • 9. Variants in the HEPSIN gene are associated with susceptibility to prostate cancer.
    Kim HJ, Han JH, Chang IH, Kim W, Myung SC.
    Prostate Cancer Prostatic Dis; 2012 Dec 01; 15(4):353-8. PubMed ID: 22665141
    [Abstract] [Full Text] [Related]

  • 10. Common variants in IGF1 pathway genes and clinical outcomes after radical prostatectomy.
    Chang CF, Pao JB, Yu CC, Huang CY, Huang SP, Yang YP, Huang CN, Chang TY, You BJ, Lee HZ, Hour TC, Bao BY.
    Ann Surg Oncol; 2013 Jul 01; 20(7):2446-52. PubMed ID: 23397154
    [Abstract] [Full Text] [Related]

  • 11. Genetic predisposition to early recurrence in clinically localized prostate cancer.
    Borque Á, del Amo J, Esteban LM, Ars E, Hernández C, Planas J, Arruza A, Llarena R, Palou J, Herranz F, Raventós CX, Tejedor D, Artieda M, Simon L, Martínez A, Carceller E, Suárez M, Allué M, Sanz G, Morote J.
    BJU Int; 2013 Apr 01; 111(4):549-58. PubMed ID: 22759231
    [Abstract] [Full Text] [Related]

  • 12. Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
    Chen YC, Kraft P, Bretsky P, Ketkar S, Hunter DJ, Albanes D, Altshuler D, Andriole G, Berg CD, Boeing H, Burtt N, Bueno-de-Mesquita B, Cann H, Canzian F, Chanock S, Dunning A, Feigelson HS, Freedman M, Gaziano JM, Giovannucci E, Sánchez MJ, Haiman CA, Hallmans G, Hayes RB, Henderson BE, Hirschhorn J, Kaaks R, Key TJ, Kolonel LN, LeMarchand L, Ma J, Overvad K, Palli D, Pharaoh P, Pike M, Riboli E, Rodriguez C, Setiawan VW, Stampfer M, Stram DO, Thomas G, Thun MJ, Travis RC, Virtamo J, Trichopoulou A, Wacholder S, Weinstein SJ.
    Cancer Epidemiol Biomarkers Prev; 2007 Oct 01; 16(10):1973-81. PubMed ID: 17932344
    [Abstract] [Full Text] [Related]

  • 13. Single nucleotide polymorphisms and haplotypes in the gene for vascular endothelial growth factor and risk of prostate cancer.
    Langsenlehner T, Langsenlehner U, Renner W, Krippl P, Mayer R, Wascher TC, Kapp KS.
    Eur J Cancer; 2008 Jul 01; 44(11):1572-6. PubMed ID: 18514506
    [Abstract] [Full Text] [Related]

  • 14. Association between cytochrome CYP17A1, CYP3A4, and CYP3A43 polymorphisms and prostate cancer risk and aggressiveness in a Korean study population.
    Han JH, Lee YS, Kim HJ, Lee SY, Myung SC.
    Asian J Androl; 2015 Jul 01; 17(2):285-91. PubMed ID: 25337833
    [Abstract] [Full Text] [Related]

  • 15. Association study between common variations in some candidate genes and prostate adenocarcinoma predisposition through multi-stage approach in Iranian population.
    Beikzadeh B, Angaji SA, Abolhasani M.
    BMC Med Genet; 2020 Apr 15; 21(1):81. PubMed ID: 32295536
    [Abstract] [Full Text] [Related]

  • 16. Effects of functional genetic polymorphisms in the CYP19A1 gene on prostate cancer risk and survival.
    Kanda S, Tsuchiya N, Narita S, Inoue T, Huang M, Chiba S, Akihama S, Saito M, Numakura K, Tsuruta H, Satoh S, Saito S, Ohyama C, Arai Y, Ogawa O, Habuchi T.
    Int J Cancer; 2015 Jan 01; 136(1):74-82. PubMed ID: 24803183
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Association of genetic polymorphisms in vitamin D receptor gene and susceptibility to sporadic prostate cancer.
    Onen IH, Ekmekci A, Eroglu M, Konac E, Yesil S, Biri H.
    Exp Biol Med (Maywood); 2008 Dec 01; 233(12):1608-14. PubMed ID: 18849534
    [Abstract] [Full Text] [Related]

  • 20. Apoptosis gene polymorphisms and risk of prostate cancer: a hospital-based study of German patients treated with brachytherapy.
    Meyer A, Coinac I, Bogdanova N, Dubrowinskaja N, Turmanov N, Haubold S, Schürmann P, Imkamp F, von Klot C, Merseburger AS, Machtens S, Bremer M, Hillemanns P, Kuczyk MA, Karstens JH, Serth J, Dörk T.
    Urol Oncol; 2013 Jan 01; 31(1):74-81. PubMed ID: 21396839
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.